Magdalena Klanova

4PUBLICATIONS
20CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 09, 2026
Single Cell RNA Transcriptomics of Mantle Cell Lymphoma Reveals the Presence of Treatment-Resistant Subclones at the Time of Diagnosis.

Dmitry Manakov, Magdalena Klanova, Michal Kolar

|Sep 11, 2025
Risk of central nervous system versus systemic relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP: What should we focus on?

Magdalena Klanova, Samuel Hricko, Michal Masar

|Aug 20, 2025
TUB-010, a Novel Anti-CD30 Antibody-Drug Conjugate Based on Tub-Tag Technology, Widens the Therapeutic Window by Reducing Toxicity While Maintaining High Efficacy.

Marcus Gerlach, Saskia Schmitt, Philipp Cyprys

|Jan 09, 2019
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.

Magdalena Klanova, Laurie H Sehn, Isabelle Bence-Bruckler

Pageof 1

Frequent Collaborators

1 joint publications

Isabelle Bence-Bruckler

1 joint publications

Federica Cavallo

1 joint publications

Maurizio Martelli

1 joint publications

Umberto Vitolo